نتائج البحث - "Ríos-Tamayo, Rafael"

المساهمون: Botta, Cirino, Perez, Cristina, Larrayoz, Marta, Puig, Noemi, Cedena, Maria-Teresa, Termini, Rosalinda, Goicoechea, Ibai, Rodriguez, Sara, Zabaleta, Aintzane, Lopez, Aitziber, Sarvide, Sarai, Blanco, Laura, Papetti, Daniele M, Nobile, Marco S, Besozzi, Daniela, Gentile, Massimo, Correale, Pierpaolo, Siragusa, Sergio, Oriol, Albert, González-Garcia, Maria Esther, Sureda, Anna, de Arriba, Felipe, Rios Tamayo, Rafael, Moraleda, Jose-Maria, Gironella, Mercede, Hernandez, Miguel T, Bargay, Joan, Palomera, Lui, Pérez-Montaña, Albert, Goldschmidt, Hartmut, Avet-Loiseau, Hervé, Roccaro, Aldo, Orfao, Alberto, Martinez-Lopez, Joaquin, Rosiñol, Laura, Lahuerta, Juan-José, Blade, Joan, Mateos, Maria-Victoria, San-Miguel, Jesús F, Martinez Climent, Jose-Angel, Paiva, Bruno

مصطلحات موضوعية: Settore INF/01 - Informatica, Settore MED/15 - Malattie del Sangue

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37730678; volume:14; issue:1; firstpage:5825; journal:NATURE COMMUNICATIONS; https://hdl.handle.net/10278/5042100Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85171810286

الإتاحة: https://doi.org/10.1038/s41467-023-41562-6Test
https://hdl.handle.net/10278/5042100Test

View record in BASE

4

دورية أكاديمية

A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study

المؤلفون: Ríos-Tamayo, Rafael, Soler, Juan Alfons, García-Sánchez, Ricarda, Pérez Persona, Ernesto, Arnao, Mario, García-Guiñón, Antoni, Domingo, Abel, González-Pardo, Miriam, de la Rubia Comos, Javier, Mateos, Maria-Victoria, GeminiS Study Investigators

مصطلحات موضوعية: Relapsed-refractory multiple myeloma, Real-world, Monoclonal antibodies, Daratumumab, Standard of care, 32 Ciencias Médicas

العلاقة: http://hdl.handle.net/20.500.12466/4403Test

الإتاحة: https://doi.org/20.500.12466/440310.1080/16078454.2023.2178997Test
https://hdl.handle.net/20.500.12466/4403Test

View record in BASE

5

دورية أكاديمية

Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based Approach

المؤلفون: Ríos Tamayo, Rafael, Sánchez Pérez, María José

مصطلحات موضوعية: Bone marrow aspirate, Cytomorphology, Next generation flow, Differential cell counts, 200 vs 500 cutoffs, ISO15189, Preanalytical quality, Multiple myeloma, Plasma cells, Blasts, Diagnostic efficiency, Clinical laboratory, Clinical significance

العلاقة: Ríos-Tamayo, R.; Sánchez, M.J.; Gómez-Rojas, S.; Rodríguez-Barranco, M.; Segura, G.P.; Redondo-Sánchez, D.; CARREÑO-TARRAGONA, G.; Nicolás, A.R.; Ruiz-Cabello, F.; Jiménez, P.; et al. Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based Approach. Diagnostics 2023, 13, 1071. [https:// doi.org/10.3390/ diagnostics13061071]; https://hdl.handle.net/10481/81570Test

الإتاحة: https://hdl.handle.net/10481/81570Test

View record in BASE

6

دورية أكاديمية

Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

المؤلفون: Rosiñol Dachs, Laura, Montes Gaisán, Carmen, Bustamante, Gabriela, Garzón López, Sebastián, González García, Esther, Pérez Persona, Ernesto, González Calle, Verónica, Sirvent Auzmendi, Maialen, Arguiñano Pérez, José María, González Montes, Yolanda, Ríos Tamayo, Rafael, Miguel Llorente, Dunia de, Palomera Bernal, Luis, Sampol Mayol, Antonia, Couto Caro, Carmen, Grande, Marta, Fernández Nistal, Alonso, Naves, Andrea, Ocio San Miguel, Enrique María

المساهمون: Universidad de Cantabria

المصدر: Leukemia & Lymphoma, 2023, 64(11), 1847-1856

مصطلحات موضوعية: Multiple myeloma, Relapsed/refractory multiple myeloma, Quality of life, Health‐related quality of life, EORTC QLQ-MY20 assessment, Burden of the disease

العلاقة: https://doi.org/10.1080/10428194.2023.2240922Test; https://hdl.handle.net/10902/31272Test

الإتاحة: https://doi.org/10.1080/10428194.2023.2240922Test
https://hdl.handle.net/10902/31272Test

View record in BASE

7

دورية أكاديمية

Randomized phase II study of weekly carfilzomib 70 mg/m(2) and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients

المؤلفون: Pueras, Borja, González-Calle, Verónica, Sureda, Anna, Moreno, María José, Oriol, Albert, González, Esther, Rosiñol, Laura, López, Jordi, Escalante, Fernando, Martínez-López, Joaquín, Carrillo, Estrella, Clavero, Esther, Ríos-Tamayo, Rafael, Rey-Bua, Beatriz, González-Rodríguez, Ana Pilar, Dourdil, Victoria, Arriba, Felipe de, González, Sonia, Ocio San Miguel, Enrique María

المساهمون: Universidad de Cantabria

المصدر: Haematologica, 2023, 108(10), 2753-2763

العلاقة: https://hdl.handle.net/10902/31012Test

الإتاحة: https://doi.org/10.3324/haematol.2022.282490Test
https://hdl.handle.net/10902/31012Test

View record in BASE

النص الكامل

8

دورية أكاديمية

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

المؤلفون: Rosiñol, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne Laurène, Ríos Tamayo, Rafael, Hulin, Cyrille, Blanchard, María Jesús, Caillot, Denis, Sureda, Anna, Hernández, Miguel Teodoro, Arnulf, Bertrand, Mateos, Maria Victoria, Macro, Margaret, San Miguel, Jesús, Belhadj, Karim, Lahuerta, Juan José, Garelik, M. Brigid, Bladé, Joan, Moreau, Philippe

المصدر: Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

مصطلحات موضوعية: Mieloma múltiple, Terapèutica, Multiple myeloma, Therapeutics

وصف الملف: 12 p.; application/pdf

العلاقة: Reproducció del document publicat a: https://doi.org/10.3389/fonc.2023.1197340Test; Frontiers in Oncology, 2023, vol. 13; https://doi.org/10.3389/fonc.2023.1197340Test; http://hdl.handle.net/2445/205802Test

الإتاحة: https://doi.org/10.3389/fonc.2023.1197340Test
http://hdl.handle.net/2445/205802Test

View record in BASE

النص الكامل

9

دورية أكاديمية

Randomized phase II study of weekly carfilzomib 70 mg/m 2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients

المصدر: Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

مصطلحات موضوعية: Ciclofosfamida, Mieloma múltiple, Cyclophosphamide, Multiple myeloma

وصف الملف: 11 p.; application/pdf

العلاقة: Reproducció del document publicat a: https://doi.org/10.3324/haematol.2022.282490Test; Haematologica, 2023, vol. 108, num. 10, p. 2753-2763; https://doi.org/10.3324/haematol.2022.282490Test; http://hdl.handle.net/2445/207683Test

الإتاحة: https://doi.org/10.3324/haematol.2022.282490Test
http://hdl.handle.net/2445/207683Test

View record in BASE

النص الكامل

10

دورية أكاديمية

A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study

المؤلفون: Soler, Alfons, Garcia Sanchez, Ricarda, Pérez Persona, Ernesto, Arnao Herraiz, Mario, García-Guiñón, Antoni, Domingo, Abel, González Pardo, Miriam, de la Rubia, Javier, Mateos, María-Victoria, Ríos-Tamayo, Rafael

المساهمون: Ríos-Tamayo R Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. Soler JA Department of Hematology, HospitalUniversitari Parc Taulí de Sabadell, Catalonia, Spain. García-Sánchez R Department of Hematology, Hospital Virgen de la Victoria, Málaga, Spain. Pérez Persona E Department of Hematology, Hospital Universitario de Navarra, Pamplona, Spain. Arnao M Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain. García-Guiñón A Department of Hematology, Hospital Universitari Arnau de Vilanova, Lleida, Spain. Domingo A Department of Hematology, Hospital General de Granollers, Granollers, Spain. González-Pardo M Medical Department, Janssen-Cilag España, Spain. de la Rubia J Hospital Universitari i Politècnic La Fe, Valencia, Spain. Hematology Department, Universidad Católica“San Vicente Mártir”, Valencia, Spain. CIBERONC CB16/12/00284,Valencia, Spain. Mateos MV Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Hospital Universitario de Salamanca, Salamanca, Spain, Hospital General de Granollers

المصدر: Scientia

مصطلحات موضوعية: Mieloma múltiple, Anticossos monoclonals, Medicaments - Eficàcia, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Plasma Cell::Multiple Myeloma, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal, PUBLICATION CHARACTERISTICS::Study Characteristics::Multicenter Study, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células plasmáticas::mieloma múltiple, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales, CARACTERÍSTICAS DE PUBLICACIONES::características del estudio::estudio multicéntrico

وصف الملف: application/pdf

العلاقة: Hematology;28(1); https://doi.org/10.1080/16078454.2023.2178997Test; Ríos-Tamayo R, Soler JA, García-Sánchez R, Pérez Persona E, Arnao M, García-Guiñón A, et al. A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study. Hematology. 2023 Dec;28(1):2178997.; https://hdl.handle.net/11351/9425Test

الإتاحة: https://doi.org/10.1080/16078454.2023.2178997Test
https://hdl.handle.net/11351/9425Test

View record in BASE

تنقيح النتائج